Article Versions Notes

Paroli M, Becciolini A, Bravi E, Andracco R, Nucera V, Parisi S, Ometto F, Lumetti F, Farina A, Del Medico P, et al. Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study. Medicina. 2023; 59(8):1480. https://doi.org/10.3390/medicina59081480

Paroli, Marino, Andrea Becciolini, Elena Bravi, Romina Andracco, Valeria Nucera, Simone Parisi, Francesca Ometto, Federica Lumetti, Antonella Farina, Patrizia Del Medico, and et al. 2023. "Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study" Medicina 59, no. 8: 1480. https://doi.org/10.3390/medicina59081480

Paroli, M., Becciolini, A., Bravi, E., Andracco, R., Nucera, V., Parisi, S., Ometto, F., Lumetti, F., Farina, A., Del Medico, P., Colina, M., Lo Gullo, A., Ravagnani, V., Scolieri, P., Larosa, M., Priora, M., Visalli, E., Addimanda, O., Vitetta, R., ... Ariani, A. (2023). Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study. Medicina, 59(8), 1480. https://doi.org/10.3390/medicina59081480